JOURNAL ARTICLE
Stem cell therapies 'come of age' with two conditional approvals in Japan: Induced pluripotent stem cells could help treat diseased hearts and brains.
Published In: Sciencemag.org, 2026. P. N.PAG 1 of 3
Database: Applied Science & Technology Source Ultimate 2 of 3
Authored By: Normile, Dennis 3 of 3
Abstract
The article focuses on the recent progress and regulatory approval of therapies using induced pluripotent stem (iPS) cells in Japan for treating heart failure and Parkinson’s disease. Developed primarily at Kyoto University, these therapies utilize iPS cells—stem cells reprogrammed from adult cells—to regenerate damaged tissues while minimizing ethical concerns and immune rejection. Japan’s health ministry has granted conditional marketing approval for these treatments under a system that allows sales for up to seven years while further efficacy studies continue, bypassing traditional lengthy phase 3 trials. Meanwhile, other countries pursue more conventional clinical trial pathways for iPS and embryonic stem (ES) cell therapies, which remain under investigation for various diseases including diabetes, Parkinson’s, and epilepsy. [Extracted from the article]
Additional Information
- Source:Sciencemag.org. 2026/03, pN.PAG
- Document Type:Article
- Subject Area:Health and Medicine
- Publication Date:2026
- Accession Number:192125640
- Copyright Statement:Copyright of Sciencemag.org is the property of American Association for the Advancement of Science and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.